Medigene AG (PK) News - MDGEF

Deleted Symbol

Thu, Sep 05, 2013 12:00 - MediGene AG (MDGEF: Grey Market) - Deleted Symbol - As of Thu, Sep 05, 2013, MDGEF is no longer a valid symbol. You may...

Annual Result 2005 and Forecast 2006 of MediGene AG: Significant Increase in Revenues and Improved Result

* Total revenues increased by 50% to 19.7 million euro (2004: 13.1 million euro) * Operating loss (EBIT) reduced by 22% to -11.5 million euro...

MediGene AG Decides to Raise EUR 15.6 MM in a Share Capital Increase

MARTINSRIED, Germany and SAN DIEGO, March 2 /PRNewswire-FirstCall/ -- The Executive Board of the German-American biotech company MediGene AG...

MediGene's Prostate Cancer Drug* Launched in France and Other European Countries

- MediGene Receives Milestone Payment for Launch in France - MediGene's First Drug* Now Available in 11 European Countries MARTINSRIED, Germany...

MediGene to Present at BIO CEO & Investor Conference in New York City

MARTINSRIED/MUNICH, Germany and SAN DIEGO, Feb. 14 /PRNewswire-FirstCall/ -- The German-American biotech company MediGene AG (German Stock...

MediGene and Bradley Pharmaceuticals Enter Marketing and Development Partnership for Polyphenon(R) E Ointment

* Bradley acquires US commercialization rights for genital warts and other dermatological diseases. MediGene retains full rest of world...

MediGene Receives One-Time Payment for License Agreement with Glaxo Group

* A non-exclusive license under existing tumor-vaccine patents MARTINSRIED, Germany and MUNICH, Germany, and SAN DIEGO, Dec. 19...

MediGene Announces FDA Acceptance of New Drug Application for Polyphenon(R) E* Ointment for the Treatment of Genital Warts

MARTINSRIED and MUNICH, Germany and SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ -- The German-American biotech company MediGene AG (Frankfurt...

MediGene AG Announces Nine-Months Result and Confirms Forecast for the Year

* Total revenues of 8.6 million euro (9M-2004: 11.5 million euro) MARTINSRIED/MUNICH, Germany and SAN DIEGO, Nov. 2 /PRNewswire-FirstCall/...

MediGene AG Initiates Clinical Phase II - Trial of EndoTAG(TM)-1* in Advanced Pancreatic Cancer

MARTINSRIED, Germany and SAN DIEGO, Aug. 24 /PRNewswire-FirstCall/ -- Today the German-American biotech company MediGene AG (Frankfurt, Prime...

MediGene AG Announces 6-Months Result and Confirms Forecast for the Year

* Total revenues of 4.9 million euro (H1-2004: 8.8 million euro) * Net loss -6.3 million euro (H1-2004: -4.2 million euro) * Operational cash flow...

MediGene to Present at Fourth Annual Needham Biotechnology Conference in New York City

MediGene to Present at Fourth Annual Needham Biotechnology Conference in New York City MARTINSRIED/MUNICH, Germany and SAN DIEGO, May 23...

Again MediGene AG Significantly Improves Quarterly Result

Again MediGene AG Significantly Improves Quarterly Result * Net loss -0.9 million EUR (Q1-2004: -1.5 million EUR) * Total revenues 3.8 million EUR...

MediGene Announces Webcast of Analyst Conference and Conference Call of 2004 Year End Results

MediGene Announces Webcast of Analyst Conference and Conference Call of 2004 Year End Results Analyst Conference to be Held on March 23 in...

MediGene to Present at Rodman & Renshaw Techvest 6th Annual Healthcare Conference

MediGene to Present at Rodman & Renshaw Techvest 6th Annual Healthcare Conference MARTINSRIED, Germany and SAN DIEGO, Oct. 22...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Medigene AG (PK) (MDGEF)

Professional-Grade Tools, for Individual Investors.

MDGEF News

Deleted Symbol

Annual Result 2005 and Forecast 2006 of MediGene AG: Significant Increase in Revenues and Improved Result

MediGene AG Decides to Raise EUR 15.6 MM in a Share Capital Increase

MediGene's Prostate Cancer Drug* Launched in France and Other European Countries

MediGene to Present at BIO CEO & Investor Conference in New York City

MediGene and Bradley Pharmaceuticals Enter Marketing and Development Partnership for Polyphenon(R) E Ointment

MediGene Receives One-Time Payment for License Agreement with Glaxo Group

MediGene Announces FDA Acceptance of New Drug Application for Polyphenon(R) E* Ointment for the Treatment of Genital Warts

MediGene AG Announces Nine-Months Result and Confirms Forecast for the Year

MediGene AG Initiates Clinical Phase II - Trial of EndoTAG(TM)-1* in Advanced Pancreatic Cancer

MediGene AG Announces 6-Months Result and Confirms Forecast for the Year

MediGene to Present at Fourth Annual Needham Biotechnology Conference in New York City

Again MediGene AG Significantly Improves Quarterly Result

MediGene Announces Webcast of Analyst Conference and Conference Call of 2004 Year End Results

MediGene to Present at Rodman & Renshaw Techvest 6th Annual Healthcare Conference

MDGEF Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Medigene AG (PK) (MDGEF) News

Medigene AG (PK) (MDGEF)

Professional-Grade Tools, for Individual Investors.

MDGEF News

Deleted Symbol

Annual Result 2005 and Forecast 2006 of MediGene AG: Significant Increase in Revenues and Improved Result

MediGene AG Decides to Raise EUR 15.6 MM in a Share Capital Increase

MediGene's Prostate Cancer Drug* Launched in France and Other European Countries

MediGene to Present at BIO CEO & Investor Conference in New York City

MediGene and Bradley Pharmaceuticals Enter Marketing and Development Partnership for Polyphenon(R) E Ointment

MediGene Receives One-Time Payment for License Agreement with Glaxo Group

MediGene Announces FDA Acceptance of New Drug Application for Polyphenon(R) E* Ointment for the Treatment of Genital Warts

MediGene AG Announces Nine-Months Result and Confirms Forecast for the Year

MediGene AG Initiates Clinical Phase II - Trial of EndoTAG(TM)-1* in Advanced Pancreatic Cancer

MediGene AG Announces 6-Months Result and Confirms Forecast for the Year

MediGene to Present at Fourth Annual Needham Biotechnology Conference in New York City

Again MediGene AG Significantly Improves Quarterly Result

MediGene Announces Webcast of Analyst Conference and Conference Call of 2004 Year End Results

MediGene to Present at Rodman & Renshaw Techvest 6th Annual Healthcare Conference

MDGEF Discussion

Your Recent History